Temasek Holdings is considering selling Advanced MedTech, multiple sources told Reuters on Monday, after the medical devices firm, fully-owned by the Singaporean state investor, received interest from suitors including buyout funds.
Two investment banks have been hired to launch a sale process for Singapore-headquartered MedTech, which could be valued at roughly $1 billion, two of the sources said.
All the sources declined to be named as news of the sale process has not been made public.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
A Temasek spokesperson declined comment, while there was no immediate comment from an external spokesperson for Advanced MedTech.
Temasek is a global investment company with a net portfolio value of S$381 billion (US$283b) as at 31 March 2021. Headquartered in Singapore, it has 13 offices in 9 countries around the world.
The Temasek Charter defines Temasek’s three roles as an Investor, Institution and Steward, which shape its ethos to do well, do right, and do good. As a provider of catalytic capital, it seeks to enable solutions to key global challenges.
With sustainability at the core of all Temasek does, it actively seeks sustainable solutions to address present and future challenges, as it captures investible opportunities to bring about a sustainable future for all.
Source: Reuters
Can’t stop reading? Read more
Advent eyes partial exit as Svatantra Microfin plans $250m IPO
Advent eyes partial exit as Svatantra Microfin plans $250m IPO Advent International is preparing...
Sixth Street makes UK football entry with Sunderland AFC Women majority stake
Sixth Street makes UK football entry with Sunderland AFC Women majority stake Sixth Street has...
Pimco lines up $14bn debt package for Oracle’s Michigan data centre project
Pimco lines up $14bn debt package for Oracle’s Michigan data centre project Pacific Investment...